ANG Lifesciences India Limited (BOM:540694)

ANG Lifesciences India Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-110.85	-124.13	-101.43	-2.62	403.17
Depreciation & Amortization	63.27	62.7	83.71	93.54	58.75
Loss (Gain) From Sale of Assets	-0.32	-	-	-8.44	1.06
Provision & Write-off of Bad Debts	3.24	4.52	10.95	9.76	21.37
Other Operating Activities	69.51	-7.86	-35.51	106.4	213.35
Change in Accounts Receivable	-17.16	62.86	114.22	179.31	-452.18
Change in Inventory	63.53	-63.43	7.21	-115.28	-177
Change in Accounts Payable	-135.65	-5.92	-44.03	-22.21	253.31
Change in Other Net Operating Assets	174.73	68.7	-130.08	23.33	-74.65
Operating Cash Flow	110.3	-2.55	-94.95	263.77	247.17
Operating Cash Flow Growth	-	-	-	6.72%	170.31%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-4.39	-37.51	-55.69	-104.45	-413.45
Sale of Property, Plant & Equipment	7.97	-	244.96	-	-
Investment in Securities	1.83	19.38	4.37	4.53	-34.34
Other Investing Activities	5.08	2.26	5.28	6.67	3.68
Investing Cash Flow	10.48	-15.87	198.92	-93.25	-444.1

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	6.5	56.3	53.97	-	175.14
Long-Term Debt Issued	-	55.58	-	-	114.08
Total Debt Issued	6.5	111.88	53.97	-	289.22
Short-Term Debt Repaid	-	-	-	-16.56	-
Long-Term Debt Repaid	-46.85	-11.31	-51.59	-56.69	-
Lease Payments	-11.31	-11.31	-10.69	-3.09	-
Total Debt Repaid	-46.85	-11.31	-51.59	-73.25	-
Net Debt Issued (Repaid)	-40.35	100.57	2.38	-73.25	289.22
Issuance of Common Stock	-	-	-	20	-
Common Dividends Paid	-	-	-	-	-10.35
Other Financing Activities	-77.07	-83.75	-106.4	-117.49	-79.59
Financing Cash Flow	-117.42	16.82	-104.03	-170.74	199.28

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	3.37	-1.61	-0.06	-0.22	2.35

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	105.91	-40.07	-150.63	159.33	-166.28
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	11.40%	-4.32%	-10.31%	7.25%	-4.69%
Free Cash Flow Per Share	8.11	-3.07	-11.54	12.26	-12.83
Levered Free Cash Flow	81.83	-33.05	-211.96	92.18	-206.34
Unlevered Free Cash Flow	131.42	22.45	-147.45	162.13	-154.59
Free Cash Flow After Leases	94.6	-51.38	-161.32	156.23	-166.28

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	77.07	83.75	106.4	117.49	79.59
Cash Income Tax Paid	0.44	42.27	134.1	34.59	5.27
Change in Working Capital	85.44	62.22	-52.68	65.15	-450.53

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 25, 2026

Data Sources Report a data error